Treatment News : 100% Cure Rate for Hep C With Sofosbuvir, Ledipasvir Combo Therapy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 13, 2013

100% Cure Rate for Hep C With Sofosbuvir, Ledipasvir Combo Therapy

CROI 2013An all-oral combination therapy of sofosbuvir, ledipasvir and ribavirin boasts a 100 percent cure rate among people with hepatitis C virus (HCV), reports. Edward Gane from Auckland Clinical Studies presented these most recent results from the Gilead Sciences–sponsored ELECTRON study at the 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta.

The researchers gave the nucleotide analog polymerase inhibitor sofosbuvir (GS-7997) along with the NS5A replication complex inhibitor ledipasvir (GS-5885) to 25 people with hep C who had never taken therapy and to nine who had failed a previous therapy, all of them with genotype 1 of the virus, the most difficult to treat. Four weeks into the 12-week treatment, every treatment naive participant and all but one of the null responder group experienced a rapid virologic response (RVR). By the end of therapy, all participants had a fully suppressed viral load, and at the four- and 12-week points after therapy, 100 percent of the group maintained a sustained virologic response (SVR, considered a cure).

The therapy was generally safe and well tolerated. Serious side effects included bloody urine (36 percent, mostly in women), severe anemia (20 percent) and increased coagulation (8 percent). Common and less serious side effects included mild-to-moderate anemia (20 percent), depression (8 percent) and headache (4 percent).

A current Gilead-sponsored Phase III trial is investigating a single combination therapy pill of sofosbuvir and ledipasvir. In addition, researchers plan to test the two drugs without ribavirin.

To read the story, click here.

To read the CROI abstract, click here.

Search: hepatitis C, hep C, HCV, sofosbuvir, ledipasvir, ribavirin, all-oral, Edward Gane, Auckland Clinical Studies, Gilead Sciences, ELECTRON, 20th Conference on Retroviruses and Opportunistic Infections, CROI, GS-7997, GS-5885.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:

  comments 1 - 15 (of 15 total)    

Keith Dettling, Cranbrook, BC, 2015-02-12 20:33:30
How do I get in the trial?

Janet Hall, Atlanta, GA, 2014-10-02 11:03:36
I have tried several different treatments over the last 15+ years. Because of the hardwork of a very special nurse I was able to get on the end of the Trial that inc. Sofosbuvir/GS-5885/ribavirin for 24 weeks. After just 2 weeks of treatment the virus was undetectable. The side effects were minimal. I agreed to the 3 years going back to check for the virus and go today for my 1st 24 week check up today. I not only feel great, I also am feeling blessed! This is the miracle cure!!! Good luck.

John Weaver, Eureka, CA, 2014-05-31 22:26:52
I would like to participate in any clinical trials involving these protocols. I have had Interferon/Ribavirin therapy 24 wks RNA 3000, Interferon/Ribavirin, and Vic trellis. RNA undetectable after 2 weeks but ultimately returned. Last therapy was 26 months ago.

John Weaver, Eureka, CA 95503, 2014-05-14 14:11:38
First 2 Interferon therapies, last with Victrellis a protease inhibitor failed. How do I get into therapy with sofosbuvir/ledipasvir? Insurance said they would pay.

alan w., oakland, 2014-03-15 02:00:20
will be happy to try new oral combo, since interferon run was a disaster. thanks!

ejaz iqbal, delhi, 2014-02-21 00:54:15
Can sofosbuvir be given to renal transplant patient?c.Can it be given to such patients in combination with ledispesvir?

Zulfi hussaini, Mumbai, 2014-02-12 11:21:16
My mom is suffering from hep c genotype 1b can it be cured in mumbai

d. jones, tracy, ca., 2013-12-26 10:50:28
how do i get this new med? i tested positive in 1992. is there a way i can get this with the 1034.$ a month i get on soc sec disability.

N. Bailey, San Antonio, 2013-11-12 22:35:28
My military insurance and doctors have me on the short list as soon as this is approved. I hope I can tolerate it. We have been waiting!

Dan P, Dante Virginia, 2013-08-07 21:32:50
I am sooooo excited! I am HepC positive and am on liver transplant list...My dr just told me of this regim and wants to put me on this trial...I have had interferon before and bottomed my platelets so had to quit. Virus count went right back up...I have been fighting this for going on 12 years...Prayers answered...sad for all those folks who died waiting for this cure and even the hope that one was on the horrizon. Thank you

Ara Mouradian, Ventura, Ca., 2013-06-02 14:19:41
Hello, I've been waiting for Hep c help for 20 years. Why do I have constantly read about how others are achieving success in treating this disease?. Why can't I be the one to receive those drugs that work?, why is it always someone or somewhere else?. Why do articles about cures always leave me biting my finger nails? Articles bragging about cure rates, but with no Dr.'s names or health care facilities names. Bless us all.

Mike Lesko, vancouver bc, 2013-05-06 00:46:29
I read about this in my local paper and was wondering how I could get on as part of this trial. I have been on a couple of test studies before they both were successful as long as I was on the study as soon as stopped my liver enzymes went back to what they were. So I am extremely interested in joining your study! Thank you Mike Lesko

asmara, weslaco texas, 2013-04-11 22:31:42
so you are just taking the ledipasvir(GS-5885) and the sofosbuvir (GS-7977), no Ribavirin? Glad to hear it is working well for you. Are you allowed to take any supplements like Milk thistle, vitamins, etc. during you trial?

Lisa, San Rafael, 2013-03-21 18:55:29
I'm in a clinical trial, taking 400mg Sofosbuvir/GS-5885 90 mg. It's a miracle after 4 prior tries with Interferon, I cleared inside the first month...but I'm experiencing significant side-effects. Light headed, emotional, weakness. I couldn't work if I had to. My 1st try on Interferon, they told me that would be manageable and it WASN'T, I was made to feel like I was crazy. Same thing now..if it's so tolerable, why do I feel so bad? Lots of hair loss too! This Rx is much better though...

hepcflorida, Saint Petersburg, 2013-03-15 14:17:01
When will this new therapy be available?

comments 1 - 15 (of 15 total)    

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.